Observational studyBMC pediatrics2024
Role of fibroblast growth factor-23 as an early marker of metabolic bone disease of prematurity.
Sandra Llorente-Pelayo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it